| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2020 | TTOO T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | Sell | 3,283 | $0.88 | $2,889.04 | -5.7% | |
| Feb 3, 2020 | GH Guardant Health, Inc. | Clark Ian T66 | Director | Sell | 2,690 | $76.23 | $205,058.70 | -67.4% | |
| Feb 3, 2020 | TTOO T2 Biosystems, Inc. | Lowery Thomas J. | Chief Scientific Officer | Sell | 7,535 | $0.88 | $6,630.80 | -10.8% | |
| Feb 3, 2020 | DHR Danaher Corp /de/ | McGrew Matthew66 | EVP &Chief Financial Officer | Sell | 11,304 | $161.98 | $1,831,029.71 | -21.0% | |
| Feb 3, 2020 | DHR Danaher Corp /de/ | Lalor Angela S | SVP, Human Resources | Sell | 18,267 | $161.49 | $2,949,846.50 | -32.2% | |
| Feb 3, 2020 | DHR Danaher Corp /de/ | Comas Daniel L | EVP | Sell | 82,464 | $161.50 | $13,317,658.94 | -10.5% | |
| Feb 3, 2020 | CSTL Castle Biosciences Inc | Sofinnova Healthquest Partners, L.P. | 10% Owner | Sell | 50,000 | $30.54 | $1,526,912.50 | -1.4% | |
| Feb 3, 2020 | CSTL Castle Biosciences Inc | Kabakoff David S74 | Director, 10% Owner | Sell | 50,000 | $30.54 | $1,526,912.50 | -1.4% | |
| Jan 31, 2020 | DHR Danaher Corp /de/ | Blair Rainer63 | Executive Vice President | Sell | 36,440 | $163.50 | $5,957,881.04 | -14.8% | |
| Jan 31, 2020 | DHR Danaher Corp /de/ | Joyce Thomas Patrick Jr | President And CEO | Sell | 132,474 | $162.51 | $21,527,890.26 | -7.3% | |
| Jan 31, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 50,000 | $1.44 | $71,750.00 | - | |
| Jan 31, 2020 | IQV Iqvia Holdings Inc. | Evanisko Michael J | Director | Sell | 6,250 | $155.19 | $969,937.50 | -54.3% | |
| Jan 30, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.47 | $147,000.00 | - | |
| Jan 28, 2020 | CSTL Castle Biosciences Inc | Sofinnova Healthquest Partners, L.P. | 10% Owner | Sell | 25,000 | $30.02 | $750,492.50 | -1.4% | |
| Jan 28, 2020 | CSTL Castle Biosciences Inc | Kabakoff David S74 | Director, 10% Owner | Sell | 25,000 | $30.02 | $750,492.50 | -1.4% | |
| Jan 27, 2020 | GH Guardant Health, Inc. | Clark Ian T66 | Director | Sell | 538 | $77.31 | $41,592.78 | -29.2% | |
| Jan 24, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 50,000 | $1.58 | $79,000.00 | - | |
| Jan 24, 2020 | IQV Iqvia Holdings Inc. | Evanisko Michael J | Director | Sell | 6,250 | $159.07 | $994,187.50 | -54.3% | |
| Jan 23, 2020 | TTOO T2 Biosystems, Inc. | McDonough John | Director | Sell | 57,417 | $1.15 | $66,029.55 | -10.1% | |
| Jan 23, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 50,000 | $1.63 | $81,500.00 | - | |
| Jan 17, 2020 | A Agilent Technologies, Inc. | Grau Dominique70 | Senior Vice President | Sell | 9,033 | $90.00 | $812,970.00 | -8.5% | |
| Jan 17, 2020 | IQV Iqvia Holdings Inc. | Evanisko Michael J | Director | Sell | 6,250 | $160.76 | $1,004,750.00 | -54.3% | |
| Jan 17, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 22,262 | $1.56 | $34,728.72 | - | |
| Jan 16, 2020 | EXAS Exact Sciences Corp | Cole G Bradley | General Manager - Diagnostics | Sell | 10,000 | $90.30 | $903,000.00 | -53.6% | |
| Jan 16, 2020 | VCYT Veracyte, Inc. | Kennedy Keith | COO / CFO | Sell | 7,052 | $30.08 | $212,104.41 | -6.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.